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Neurodevelopment and ages of onset in depressive disorders
Cindy C Hagan, Julia M E Graham, Paul O Wilkinson, Nick Midgley, John Suckling, Barbara J Sahakian, Ian M Goodyer
How and why do clinical depressive disorders emerge in adolescence? In this Personal View, we present a 
neurodevelopmental theory to address causes for adolescent onsets of clinical depressive disorders. We argue that 
theories should account for three perplexing aspects of depressive disorders in adolescence: the episodic nature of 
depression; diff erences between sexes in rates of depression across development; and age-diff erentiated onsets. We 
consider how theories such as psychosocial acceleration, heterochronic brain development, dual-process models, 
glucocorticoid vulnerability hypothesis linked to early life stress, and epigenetic and genetic susceptibility might 
explain some aspects of adolescent depressive disorders. We argue that some synthesis between existing theories 
might be needed to establish a suffi  cient neurodevelopmental theoretical framework to explain onsets of depressive 
disorders in adolescence.
Introduction 
About half of all adult mental illnesses emerge in 
adolescence,1 with clinical depressive disorders con-
tributing the greatest incidence risk, but little is known 
as to how or why this pattern occurs. Diff erent theories 
have attempted to explain this early emergence, including 
accelerated maturation of sex hormones,2 aberrant brain 
development,3–6 abnormal responses to life stress,7,8 and 
diff erences in genetic and environmental susceptibility9–11 
(fi gure). However, no single theory alone provides a 
satisfactory neurodevelopmental answer.
In view of the perplexing manifestations of depressive 
illness, such as episodic occurrences,12 a female pre-
ponderance,13,14 and adolescent onsets,1,11,13,14 might more 
than one of these theories contribute to the explanation 
of the developmental onset of depressive disorders in 
adolescence? We argue that a hybrid of these theories is 
might be necessary to explain the develop mental 
emergence of depressive illnesses.
Psychosocial acceleration
Adolescence is a period of rapid brain and psychosocial 
development. Psychosocial acceleration theory suggests 
that the timing of hormonal maturation varies as a 
function of an individual’s responsiveness to their 
rearing environment (via genetic or epigenetic 
mechanisms) and rearing environmental stability.2 
Findings confi rm that early and later pubertal timing are 
associated with various poor health outcomes in adult 
life, including depression.15 Unstable environmental 
rearing conditions are associated with greater un-
predictability and uncertainty than are stable conditions, 
and might therefore induce stress in an individual, with 
behaviours such as indecisiveness and over-reactivity 
generalised to subsequently encountered environments. 
Individuals have to adapt more often in unstable 
environments than in stable environments, and such 
instability has been suggested to accelerate maturation in 
some individuals, but also render them susceptible to the 
development of mental illnesses, such as depression.16 A 
positive association has been reported between pubertal 
timing and self-reported depression in a large population 
sample of adolescents,17 but pubertal acceleration alone 
does not explain how the 1:1 incidence ratio of female to 
male depression in childhood becomes 2:1 in adolescence 
and adulthood.18 Gender socialisation might account for 
sex diff erences in rates of mental illness19 and neuro-
development. For example, in instances of domestic 
abuse in which an individual has little control, female 
adolescents might favour socialising with delinquent 
peers over spending time at home more often than would 
male adolescents.19 Repeatedly experienced throughout 
development, these socialisation diff erences might partly 
account for neurodevelopmental sex diff erences.20 
Additionally, changes in the primary caregiver, parental 
absence, or the introduction of a step-parent are examples 
of rearing environment changes that might also partly 
explain sex-related and age-related eff ects of mental 
illness. Considered together, sex might independently 
and interactively aff ect the developing brain21 and 
increase the proneness of some individuals to develop 
depression in adolescence.
Heterochronic brain development
Human brain development is heterochronic, meaning that 
diff erent developmental timings and rates of change are 
shown across regions.22 Some researchers propose that 
atypical brain maturation, in combination with psycho-
social, environmental, and biological factors, predisposes 
adolescents to diff erent forms of psychopathological 
changes, including major depressive disorder.3 More 
recently, neuroimaging analysis techniques have been 
applied that concentrate on the coordinated development 
of neural systems distributed across proximal and distal 
brain regions.23 When applied to the aberrant brain 
maturation hypothesis,3 disparities in the timing or rate of 
synapse formation within neural systems, in combination 
with psychosocial, environmental, and biological factors, 
might confer an increased susceptibility to onset of mental 
illness, with depression being particularly likely in 
adolescence and early adulthood.1
Dual-process models
Compatible with the heterochronic development of 
neural systems, dual-process models propose that 
so-called hot and cold systems underlie both typical and 
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atypical behaviour in human beings.4–6 Hot systems were 
initially proposed to underlie emotionality and cold 
systems to underlie cognition with their interplay 
comprising a skillset used during the exertion of 
willpower.5 In brief, hot systems refer to bottom-up 
emotional processing arising in lower brain regions, 
passing upwards through the limbic-system structures 
and emerging as reactive or refl exive behaviours. Cold 
systems refer to top-down cognitive processing arising 
from frontal and prefrontal regions of the brain passing 
down towards the limbic system and emerging as 
proactive or refl ective behaviours. The balance between 
hot and cold systems is driven by a set of factors, 
including developmental level, personal history, stress, 
and temperament, and can be further modulated 
by pharma cological intervention.5,6 A developmental 
imbalance between hot and cold systems is present in 
adolescence, whereby a mature hot system occurs 
alongside a relatively immature cold system.1,4 For 
example, the hot amygdala—a limbic region associated 
with the perception of biologically relevant socio-
emotional information24—matures earlier than does the 
cold hippocampus, implicated in memory, and the cold 
prefrontal cortex, implicated in the cognitive regulation 
of socioemotional stimuli.5,6,25–27 Some researchers 
therefore suggest that exaggerated neurodevelopmental 
imbalances between the refl exive hot system and the 
refl ective cold system contribute to the emergence of 
aff ective disorders in adolescence.4 Caution should be 
taken when hot and cold nomenclature is assigned to 
neuropsychological tasks, however, because individuals 
with depressive disorders might have an increased 
sensitivity to feedback on task performance, thereby 
instilling negative expectations and a reinterpretation of 
a cold cognitive task as a hot emotional task.6 
Unfortunately, cold-turned-hot thinking patterns are 
diffi  cult to change, even with medication or targeted 
brain stimulation techniques.6 Repeated cold-turned-hot 
experiences in addition to early life stressors, such as 
rearing environment instability or chronic psychosocial 
diffi  culties, could promote accelerated development of 
the hot system via prompting of over activity and 
strengthening of connections between hot regions. This 
change can leave adolescents with depression bewildered 
about their fl uctuating mood states. As one 15-year-old 
with clinical depression and a history of chronic trauma 
said: “It’s not really easy to make sense of [because] 
when you’re in that mood, you don’t think of anything 
like you don’t think logically, but then like once you’ve 
sort of calmed down and everything, I sort of sit and 
think ‘Why was I like that?’[…] And it doesn’t really make 
sense”.28 Albeit in a small sample of 30 adolescents with 
depression, a prospective longitudinal neuroimaging 
study showed developmental acceleration of the hot 
amygdala, but only in adolescent girls with depressive 
disorders in comparison to healthy adolescents.20 
Notably, adolescent boys with depressive disorders 
showed developmental attenuation of the amygdala.20 
This fi nding suggests that pathways to depressive 
disorders in adolescence could be sex-specifi c.
Could attenuated development of the cold system also 
generate an exaggerated imbalance between hot and 
cold systems therefore conferring risk for major 
depressive disorder? Reductions in hippocampal volume 
have been reported in women with depression and a 
history of abuse in childhood compared with either 
women with depression and no history of childhood 
abuse or healthy women.29 Additionally, a large meta-
analysis30 of 15 studies comprising 1728 adult patients 
with depression and 7199 healthy adults showed 
signifi cantly reduced hippocampal volume in individuals 
of both sexes who had become depressed at a young age 
(<21 years), but only for those with recurrent episodes. 
Results in adolescents with depression are less clear, 
with cross-sectional studies showing both signifi cant 
reductions and no signifi cant diff erences in hippocampal 
volumes relative to healthy controls.31,32 Some 
investigators posit that the delayed developmental 
trajectory of the hippocampus compared with the 
amygdala hinders the detection of hippocampal 
volumetric changes until adulthood.27 Longitudinal 
studies account for variance within and across 
individuals and so are better suited than cross-sectional 
studies, which only assess variance across individuals, to 
detect diff erences in the developmental trajectories of 
brain regions, such as the hippocampus during 
adolescence. Other investigators have speculated that 
exposure to environmental stressors might initially 
potentiate, but with increasing chronicity or severity 
Figure: Risk and protective factors interacting with the development of hot and cold neural systems and 
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eventually attenuate, development of the cold system in 
some individuals, leading to reduced neural connectivity 
between brain regions and protracted overall growth.5 
This view is harmonious with the suggestion that 
dysfunctional cold cognitive processes precede depressive 
illness6,25 and with prospective longitudinal data 
associating attenuated hippocampal growth in 
adolescence with development of depression in male 
and female adolescents.20
Glucocorticoid vulnerability
Attenuated development of the cold system is compatible 
with the glucocorticoid vulnerability hypo thesis, which 
suggests that chronic stress negatively interferes with 
people’s ability to withstand and overcome trauma-related 
neuropathological changes.7 Some researchers propose 
that brain structural and functional malleability (ie, 
neuroplasticity) is perturbed by chronic stress or stress 
dysregulation, contributing to the emergence of 
depressions.8 Treatment with anti depressant drugs 
inhibits and sometimes reverses neuroplastic damage, 
particularly in the hippocampus.8 The hippocampus, a 
core region of the cold system, is particularly susceptible 
to atrophy, perhaps resulting from epigenetic eff ects 
on BDNF (a trophic protein important for neuro-
development) gene expression9 or, in view of the 
abundance of glucocorticoid (specifi cally cortisol in 
human beings) receptors in the hippocampus, from 
toxic concentrations of corticoids circulating in the brain 
(ie, acquired neuro endangerment).25 Notably, patients 
with Cushing’s disease, which is associated with 
hippocampal atrophy and hypercortisolaemia resulting 
from the increased production and secretion of gluco-
corticoids, often have a depressive illness. Experiments 
in rodents7 show that stress can downregulate 
glucocorticoid receptors in the hippocampus, leading to 
an over abundance of glucocorticoids. The hippocampus 
typically exerts an inhibitory eff ect on the stress 
response. However, in conditions of chronic stress, the 
inhibitory response by the hippocampus is impaired.7 In 
line with these fi ndings in rodents, high concentrations 
of evening cortisol and symptoms of post-traumatic 
stress disorder have been related to volumetric 
reductions in the hippocampus of children with a history 
of maltreatment.33 Immediate and long-term eff ects of 
cortisol hyper secretion on the hippocampus probably 
depend on the developmental stage of the hippocampus 
at the time of stress exposure,27,33,34 the amount and 
chronicity of cortisol release induced by the stressor,27,33 
and the severity and chronicity of stress exposure.27,33 
Accordingly, an epidemiological study35 reported a 
fourfold increase in risk of childhood memory 
impairments in adults who had been exposed to more 
than three adverse experiences during childhood or 
adolescence. By contrast, acute stress in adulthood 
might lead to reparable hippocampal damage.7 Aberrant 
hippocampal function could contribute to impaired 
concentration, anhedonia, or stress dysregulation 
through connectivity with the dorsolateral prefrontal 
cortex, nucleus accumbens, and hypo thalamus.8 
Individuals with depression might be more susceptible 
to corticoid-mediated acquired neuroendangerment of 
the hippocampus, which could  therefore have down-
stream eff ects on experience-dependent learning.25 
Hence, depressive episodes could emerge in vulnerable 
adolescents when stressful life events occur and trigger 
depressive symptoms.25 A study has shown that many 
adolescents with clinical depression link the occurrence 
of depressive episodes to stressful life events, leaving 
them unable to use the refl ective cold system to regulate 
an (over)active hot system (Midgley N and colleagues, 
unpublished). A 16-year-old girl with severe depression 
who had been exposed to severe domestic violence 
between her parents explained that: “There’s loads and 
loads of things that are fl ying around in my head and I 
can’t stop them and look at them and fi nd out what 
exactly it is and what caused them, I just know that like 
when it happens it makes you feel sick and dizzy and 
just horrible” (Midgley N and colleagues, unpublished).28
Epigenetic and genetic susceptibility
Changes in BDNF gene expression is one mechanism to 
explain sex-diff erentiated risk for depression as a 
function of early life experience. Because biological sex is 
associated with diff erent rates of development in 
diff erent brain regions,21 epigenetic regulation of gene 
expression in the brain might occur in both a sex-specifi c 
and age-specifi c way.9,10 Accordingly, female mice 
repeatedly bitten by a larger, more aggressive mouse of 
the same sex showed amplifi ed social withdrawal 
behaviour and increased BDNF protein expression in the 
bed nucleus of the stria terminalis,36 a region of the brain 
associated with threat vigilance.37 Male mice do not show 
these same eff ects.36 Downregulated BDNF gene 
expression in the mouse hippocampus, induced by 
prenatal toxin exposure, has been associated with 
changes in brain function and behaviour.9 In human 
beings, peripheral blood concentrations of BDNF protein 
might indicate the state of depressive illness.38 Although 
similar concentrations of BDNF protein have been 
reported in both healthy adults and adults in full 
remission of depression, lower concentrations have been 
recorded in patients with current depression.38 A separate 
study9 showed that prenatal exposure to environmental 
toxins leads to sex-specifi c changes in DNA methylation 
of BDNF that are associated with sex-specifi c eff ects on 
behaviour in both mice and human beings. Hype-
methylation reduces gene expression of hippocampal 
BDNF and could therefore function as a biomarker for 
exposure to adversity in early life, leading to sex-
diff erentiated patterns of behaviour in later life.9 Could 
sex-specifi c methylation patterns of hippocampal BDNF 
partly explain sex and age diff erences in rates of 
depressive illness?
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Although little is known about how gene–environment 
associations aff ect human neurodevelopment and onsets 
of depressive illness,39 some evidence suggests that genes 
help to modulate adolescent development and might 
accordingly change the risk for the emergence of 
depression in the second decade of life (aged 10–19 years) 
compared with the fi rst (aged 0–9 years). One longitudinal 
twin study11 has shown that diff erential genetic eff ects are 
greater for the onset of depression in adolescence than 
for that in childhood, suggesting an additional pathway 
for sex and age diff erentiation of depressive disorders 
because such genes might also aff ect adolescent brain 
development. These gene–gene and gene–environment 
relations are yet to be fully clarifi ed and incorporated into 
a neurodevelopmental framework.
Conclusion
To summarise, synthesis between existing theories is 
needed to provide a suffi  cient neurodevelopmental 
theoretical framework with which to explain adolescent 
onsets of clinical depressions. Although alternative 
explanations cannot be ruled out, risk mechanisms might 
be diff erentially impaired among diff erent individuals, 
giving rise to the clinical heterogeneity often reported in 
depressive disorders (fi gure). Similarly, diff erent amounts 
and combinations of intervention techniques might be 
necessary for treatment of individuals with diff erent 
clinical profi les of depression (fi gure). Nevertheless, 
irrespective of the clinical mani festation of depression, 
intervention at the earliest stages of illness onset might 
be important to prevent the neural and cognitive imprints 
that fuel recurrence risks into adult life.40 To assist in the 
early detection and treatment of depression, clinicians 
working with parents, who themselves might be mentally 
unwell, could improve the education of patients about the 
environmental and physical risk factors associated with 
development of major depressive disorder, the symptoms 
of this disorder in adolescence, and could enable 
discussions to improve parent–child communication and 
interaction. Perhaps therapeutic studies of adolescents 
with depression and either a positive family history of 
major depressive disorder or early exposure to 
suboptimum environments could consider trialling 
treatment with DNA demethylases (thus normalising 
gene expression) or histone deacetylase inhibitors (which 
disrupt DNA translation) in an eff ort to mitigate 
epigenetic mani festations of the disorder.41 Furthermore, 
public health campaigns and educational establishments 
could ensure exposure of all children to enriched 
educational environ ments, assist in educating the general 
public (including adolescents) about the symptoms 
associated with major depressive disorder in adolescence, 
and disseminate knowledge about the risks associated 
with individuals who have early sexual maturation and 
development. Finally, in addition to the therapeutic 
treatment of adolescents, perhaps training interventions 
could focus on instilling positive thinking patterns and 
self-monitoring of cognitions to improve executive 
function skills. Stress regulation strategies could be 
developed and introduced as part of personal growth and 
education in schools in an eff ort to cultivate the growth of 
cold system regions and reduce the reliance on behaviours 
attributable to the hot system.4 As the parent of an 
adolescent with depression explained after a short-term 
therapeutic intervention that focused on helping 
adolescents to develop a greater balance between the 
refl ective cold and the refl exive hot processing systems: 
“He’s certainly not in the dark place where he was…he 
can now say ‘this is upsetting me’ or ‘that makes me 
angry’—he’s now able to analyse some of his feelings” 
(Midgley N and colleagues, unpublished).28 Early 
provision of treatment, be it psychological, pharma-
cological, or both, aimed to establish optimum balance 
between top-down cold and bottom-up hot cognitive 
processes, might be most eff ective for recovery from and 
relapse prevention of depression.40,42
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